Mizuma T, Benet L Z, Lin E T
Department of Biopharmaceutics, Tokyo University of Pharmacy and Life Science, Japan.
Prep Biochem Biotechnol. 1998 Feb;28(1):37-47. doi: 10.1080/10826069808010125.
Furosemide 1-O-acyl glucuronide (Fgnd) was extracted from the urine following oral administration of furosemide. The crude Fgnd was applied to micronized Amberlite XAD-2 column (2.5 cm i.d. x 90 cm length, 75-500 microns particle size). The purified Fgnd was identified by mass spectrometry and beta-glucuronidase treatment. This method was also applicable to the purification of glucuronide of tolmetin (nonsteroidal anti-inflammatory drug, NSAID), suggesting that it was applicable to the other NSAIDs, most of which were known to be metabolized to acyl-glucuronides.
口服速尿后,从尿液中提取速尿1 - O - 酰基葡萄糖醛酸苷(Fgnd)。将粗制的Fgnd应用于微粉化的Amberlite XAD - 2柱(内径2.5 cm×长度90 cm,粒径75 - 500微米)。通过质谱和β - 葡萄糖醛酸酶处理鉴定纯化后的Fgnd。该方法也适用于托美汀(非甾体抗炎药,NSAID)葡萄糖醛酸苷的纯化,这表明它适用于其他NSAID,其中大多数已知可代谢为酰基葡萄糖醛酸苷。